The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:15
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [41] Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer
    Castello, Angelo
    Grizzi, Fabio
    Toschi, Luca
    Rossi, Sabrina
    Rahal, Daoud
    Marchesi, Federica
    Russo, Carlo
    Finocchiaro, Giovanna
    Lopci, Egesta
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (07) : 636 - 644
  • [42] Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer
    Tsurugai, Yuichiro
    Kozuka, Takuyo
    Ishizuka, Naoki
    Oguchi, Masahiko
    LUNG CANCER, 2016, 92 : 47 - 52
  • [43] Clinical evaluation of proton radiotherapy for non-small-cell lung cancer
    Shioyama, Y
    Tokuuye, K
    Okumura, T
    Kagei, K
    Sugahara, S
    Ohara, K
    Akine, Y
    Ishikawa, S
    Satoh, H
    Sekizawa, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 7 - 13
  • [44] Risk Stratification by Combination of Heart and Lung Dose in Locally Advanced Non-Small-Cell Lung Cancer after Radiotherapy
    Watanabe, Yui
    Koide, Yutaro
    Shimizu, Hidetoshi
    Aoyama, Takahiro
    Shindo, Yurika
    Hashimoto, Shingo
    Tachibana, Hiroyuki
    Kodaira, Takeshi
    CANCERS, 2024, 16 (19)
  • [45] Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer
    Bernstein, ED
    Herbert, SM
    Hanna, NH
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 291 - 301
  • [46] Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non-Small-Cell Lung Cancer
    Duran, Ayse Ocak
    Inanc, Mevlude
    Bozkurt, Oktay
    Ozaslan, Ersin
    Ozkan, Metin
    CLINICAL LUNG CANCER, 2023, 24 (03) : 252 - 259
  • [47] High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer
    Allena, Aaron M.
    Shochat, Tzippy
    Flex, Dov
    Kramer, Mordechai R.
    Zer, Alona
    Peled, Nir
    Dudnik, Elizabeta
    Fenig, Eyal
    Saute, Milton
    ONCOLOGY, 2018, 95 (01) : 13 - 19
  • [48] Reduction of tumor volume during radiotherapy in patients with small-cell lung cancer and its prognostic significance
    Christian Kandler
    Khaled Elsayad
    Georg Evers
    Jan Siats
    Christopher Kittel
    Sergiu Scobioala
    Annalen Bleckmann
    Hans Theodor Eich
    Strahlentherapie und Onkologie, 2023, 199 : 1011 - 1017
  • [49] Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer
    Icht, Oded
    Domachevsky, Liran
    Groshar, David
    Dudnik, Elizabeth
    Rotem, Ofer
    Allen, Aaron M.
    Peled, Nir
    Reinhorn, Daniel
    Jacobi, Oded
    Shochat, Tzippy
    Bernstine, Hanna
    Zer, Alona
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) : E125 - E131
  • [50] Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer
    Gaines, Dakim K.
    Yegya-Raman, Nikhil
    Kim, Sinae
    Simone, Charles B., II
    Ross, Christina Theodorou
    Deek, Matthew P.
    Lam, Sarah
    Feigenberg, Steven J.
    Osorio, Benedict
    Nie, Ke
    Zou, Wei
    Patel, Malini
    Malhotra, Jyoti
    Langenfeld, John
    Aisner, Joseph
    Jabbour, Salma K.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2482 - 2488